Centers for Disease Control and Prevention (CDC)
1600 Clifton Road
Atlanta
Georgia
30333
United States
Tel: 404-639-3311
Website: http://www.cdc.gov/
Email: netinfo@cdc.gov
771 articles with Centers for Disease Control and Prevention (CDC)
-
Findings from a study support the claim that the risk of developing a serious issue, such as respiratory or cardiac issues, is much more probable in the first 30 days following infection from COVID-19.
-
Even though the COVID-19 pandemic appears to be under control, it's clear that it's not over, with the rise of more subvariants. Read on for more details.
-
Thursday, a committee of advisors for the CDC voted unanimously for children and teens, ages six to 17 to receive Moderna's COVID-19 vaccine.
-
Although COVID-19 appears to be on the run in the U.S., there is still a threat of resurgence. Here’s a look at some of the most recent COVID-19 stories and research.
-
UPDATE: In Unanimous Vote, FDA Advisory Committee Recommends Moderna's COVID Vaccine for Kids 6-17
6/14/2022
In a unanimous vote, a panel of FDA advisors voted to recommend the approval of Moderna's COVID-19 vaccine for children between the ages of six and 17 years old. -
New Quest Diagnostics Health Trends® Study, in Collaboration with CDC, Shows Less Than Half of Pregnant People Screened for Hepatitis C
6/13/2022
A new Health Trends® study from Quest Diagnostics developed in collaboration with the CDC found that the rate of hepatitis C antibody screening increased 145% in pregnant people during the decade-long study period ending June 2021.
-
On Tuesday, the FDA's Vaccines and Related Biological Products Advisory Committee voted 21-0 with one abstention to recommend authorization of Novavax’s COVID-19 vaccine.
-
CDC Study Finds Shift in Vision Impairment Trends Among Adults with Diabetes
6/4/2022
A Centers for Disease Control and Prevention study provides new insights into vision impairment prevalence over the last 20 years.
-
Nutriband Supports Update to CDC Opioid Prescribing Guidelines
6/3/2022
New proposed guidelines reiterate need for abuse deterrent technologies and call for enabling clinicians to provide comprehensive pain management including appropriate use of opioid medications.
-
Concerns are mounting for people that have been given Pfizer’s Paxlovid treatment regimen after contracting COVID-19, only to become positive for the infection once again.
-
Sunday night, U.S. health authorities announced that they may have found the third documented case of monkeypox in a patient in South Florida.
-
Celebrities' struggles with breast cancer are bringing new awareness to the importance of screening - particularly because new therapies like Radius Health's elacestrant are on the horizon.
-
Rice University researchers used the foundation of CRISPR/Cas9 technology and developed “drive-and-process” arrays, or DAP for short.
-
U.K. researchers found that the first dose of any vaccine was linked with an initial 12.8% decrease in the odds of Long COVID.
-
The European Center for Disease Prevention and Control said the number of unusual pediatric hepatitis cases has reached 450, double the number reported two weeks ago.
-
Public health officials are seeing a notable rise in cases and expressing concerns over more subvariants of the SARS-CoV-2 virus. For those stories and more, continue reading.
-
The U.S. Congress is calling for the coronavirus management plan to deliberate on the timeline for the approval and release of vaccines for children under 5 years old.
-
A new approach to improving a patient’s ability to recover from a stroke is discussed in an article published this month in Science Translational Medicine.
-
Pfizer and its partner, Valneva, have announced positive Phase II data from its trial of vaccine candidate VLA15 in a pediatric population. VLA15 is intended to prevent Lyme Disease (LD).
-
How many boosters are enough to protect against COVID-19 infection? This question has been at the forefront of the minds of everyone as news crops up about yearly boosters.